Upload
marvin-morgan
View
215
Download
0
Embed Size (px)
Citation preview
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
NIH in the Post Doubling Era:Realities and Strategies for the Future
Elias A. Zerhouni, M.D.Director
National Institutes of Health
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Competition for funds from the NIH and other sponsors, intensifying year by year, now stands at an unprecedented level, and shows no sign of abating. Never before have so many established investigators faced so much uncertainty about their longevity as active scientists. Never before have so many novices faced so many disincentives to entering or continuing a research career.
Dr. William F. Raub, NIH Associate Director for Research and Training, strategy paper, 1982
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
The budget of NIH has doubled
- but -
Success rates have dropped by a third
What is happening?
The Apparent Paradox:
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
What Is Really Happening?
Facilities building and faculty growth throughout U.S. research institutions
100% growth in applications and 75% growth in applicants per year by 2007
Budget appropriations below inflation since 2003
Budget cycling phenomenon
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
10
8
6
4
2
0
1990-1997 1998-2002 2003-2007
Dol
lars
(in
bill
ions
)
3.2B
5.4B
9.5B
Year
AAMC – Survey of Research Facility Investments (99 of 125 AAMC Member Schools) Data Based on AAMC Faculty Roster*
Investment in Research Facilities at U.S. Medical Schools
Success Rates Applications
Projected
% S
ucce
ss R
ate
of G
rant
s F
unde
d
0%
5%
10%
15%
20%
25%
30%
35%
1998 1999 2000 2001 2002 2003 2004 2005 2006 20070
10
20
30
40
50
60
+8,303
+8,359
31%
22%
Num
ber of Applications/A
pplicants (in thousands)
National Research Capacity and Demand for Grants Surges at End of Doubling Period, Success Rates Fall
19%
43,069
24,154
49,656
Success Rates Applications
Projected Num
ber of Applications/A
pplicants (in thousands)
% S
ucce
ss R
ate
of G
rant
s F
unde
d
0%
5%
10%
15%
20%
25%
30%
35%
1998 1999 2000 2001 2002 2003 2004 2005 2006 20070
10
20
30
40
50
60
43,069
Applicants
+5,334
+5,208
19%
31%
36,653
19,744
31,791
National Research Capacity and Demand for Grants Surges at End of Doubling Period, Success Rates Fall
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
NIH’s Challenge: Maintain Research Enterprise Vitality in Light of Reduced
Purchasing Power and Increased Demand
22
23
24
25
26
27
28
29
30
FY 2004 FY 2005 FY2006 FY2007
Bill
ion
s o
f D
olla
rs
Nominal funding
Adjusted by BRDPI
−8.3% loss in purchasingpower since 2004
Note: BRDPI is the Biomedical Research and Development Price Index
$25.7 B
$28.6 B$28 B
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
The Budget Cycling Phenomenon:What Funds are Available in any One Year?
NIH Appropriations
Committed Funds
Uncommitted Funds
Budget Increase
From ending grants started 4-5 years ago
From current year to previous year
Continuing grants
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
NIH Congressional Appropriations B
illi
on
s o
f D
oll
ars
DOUBLING
$13.7$15.6
$17.8
$20.5
$23.3
$27.1$28.0 $28.6 $28.6 $28.6
$0
$5
$10
$15
$20
$25
$30
FY1998
FY1999
FY2000
FY2001
FY2002
FY2003
FY2004
FY2005
FY2006
FY2007
?
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
The Bottom Line: Demand for Grants “Took Off” Just as NIH
Budget Was “Landing”!
Post doubling “boom” in applications has led to a supply/demand imbalance
Success rate drop is due to – Near 100% increased demand for grants– 40% increased costs of grants – Decrease in inflation adjusted budget
Budget cycling effect will slightly improve supply vs. demand of
grants in 2007 and beyond
Applications
Budget
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Common Misperceptions
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
56.6%53.9% 55.2% 56.4%
52.1%
53.0%
55.2% 55.8%55.2%
56.1%
40.5%39.2%
38.4% 38.5%
39.8%
40.8%
43.5%41.0% 41.0% 40.8%
5.0%7.0%
3.7%5.7% 5.5% 5.2% 4.8%
3.6%
3.1% 3.1%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
FY 1998 FY 1999 FY 2000 FY 2001 FY 2002 FY 2003 FY 2004 FY 2005 FY 2006 FY 2007
Basic Research Applied Research Other
Common Misperception 1: NIH is Over-emphasizing Applied Research
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Common Misperception 2:NIH is Shifting Towards Solicited Research
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1994 1996 1998 2000 2002 2004 2006
Fiscal Year
Per
cen
tag
e o
f G
ran
ts
Unsolicited Solicited
91% 93%
9% 8%
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Common Misperception 3:NIH Roadmap is Shifting Funds Away from Grant Pool
Roadmap1.2%
Non-Roadmap98.8%
FY2006 Budget = $28.6 B
Developed to increase synergy across NIH
Not a single initiative but over 345 individual awards in FY 2005, 133 institutions, 33 states
Estimated in FY 2006:― 51% basic― 36% translational― 13% high risk
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Where Do We Go From Here?Adaptive Strategies Based on Key
Principles
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Discovery and Generation of
New Knowledge
Principle 1:Protect Core Values and Mission
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Balanced National Biomedical Research Portfolio
NIH - $28B
Clinical Research
Basic Research
Translational Research
Private Sector - $59B
Clinical Research
Basic Research
Translational Research
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
NIH Director’s Pioneer Awards
Support individuals with untested, potentially groundbreaking ideas in many areas of science, from neuroscience to chemistry to behavioral science
Highly competitive 465 applications for 7 funded
awards in 2006 Institutes and Centers
contributed to enable funding more awards, for a total of 13
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Principle 2:Protect the Future
Five years of support consisting of two phases
Phase I provides 1-2 years of mentored support for advanced post doctoral fellows- 90k per year
Phase II provides up to 3 years of independent RO1 equivalent research support- 250k per year
NIH aiming for 150-200 awards per year
– Received ~700 applications so far
– First award announcements this Fall
Pathway to Independence Award
http://grants1.nih.gov/grants/new_investigators/index.htm
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Principle 3:Focus on Balancing Supply/Demand
Actively manage supply/demand imbalance by
adjusting programsRecycle budgets into larger number of
competing
grants (+3% in 2007)Prioritize projects to maintain reasonable
investigator-initiated success ratesMaximize research and development activities
by
managing costs across all portfoliosFacilitate peer-review processes to reduce need
for multiple applications
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Misperceptions in the MediaDeclines in Funding NIH R01 Grants
9%12%
38%
23%
35%
0%
5%
10%
15%
20%
25%
30%
35%
40%
New Unamended applications not from PAs or RFAs
New Unamended applications from PA's and RFA's
Type 1 Amendments
Competing Continuations and Supplements
Total of all Applications
Suc
cess
Rat
es,
FY
200
5
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
1998 1999 2000 2001 2002 2003 2004 2005
Fiscal Year
Nu
mb
er
R01 Equivalent* Includes R01, R23, R29 and R37
Misperceptions in the MediaNumber of R01 Equivalents Decreased
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Fiscal Year
$0
$2
$4
$6
$8
$10
$12
1998 1999 2000 2001 2002 2003 2004 2005
Fu
nd
ing
(in
Bil
lio
ns
)
R01 Equivalent* Includes R01, R23, R29 and R37
Misperceptions in the MediaR01 Funding Decreased
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Survivorship
Mill
ions
of P
eopl
e
1971 1986 1990 2003
9
6
3
Principle 4:Proactive Communication about Investment in NIH
For the first time in recorded history, annual cancer deaths in the United States have fallen
10 million cancer survivors
Improved effectiveness of early cancer detection and screening
Thanks to the doubling, new targeted, minimally invasive treatments for cancer multiplied
New drugs developed for cancer prevention
30-year investmentper American:
~$260Total
Average investmentper American
~$8.60per year
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
NIH Communication Goals
• Increase awareness of the benefits every American receives from public investment in biomedical research
• Convey to all audiences the role research will play in transforming medicine in the 21st century
• Persuade the public and private sectors of the importance of sustaining momentum in advancing knowledge and discovery
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
• NIH Homepage – More than 40 Fact Sheets– State-by-state Funding Data– Newsletter from NIH Director
http://www.nih.gov/about/researchresultsforthepublic/index.htm
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Coming to Your Doctor’s Office: Free, Authoritative, Up-to-Date
Health Information
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
22 Million Readers, Plus Website Visitors
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Mentions “National Institutes of Health” April through August
2006
Average: 4,200 per month
(Not including specific Institute and Center programs)
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
NIH Beyond the Beltway
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
2006 Is the Year…
To succeed in communicating the importance of medical research and the role of NIH…
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
Principle 5: Promote NIH’s Vision for the Future
PreemptivePersonalizedPredictive
Participatory
Elias A. Zerhouni, M.DElias A. Zerhouni, M.D.. September 2006September 2006
NIH Transforming medicine and health through discovery